Virtual 5th Annual Conference on Psychedelics and Psychedelic Medicine

November 14, 2025 to November 15, 2025

Overview

We invite you to join us Virtually for our 5th Annual Conference on Psychedelics and Psychedelic Medicine!

Please Note: The conference will be held in Eastern Daylight Time (EDT)

This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, and psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine. 

You will receive an email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the zoom instructions and attending virtually.

 

Pricing

MDs/Doctoral-Level Professionals:
Super Early Bird (on or before August 15, 2025): $475.00
Early Bird (on or before October 3, 2025): $525.00
Regular Registration (after October 3, 2025): $550.00

Other Clinicians:
Super Early Bird (on or before August 15, 2025): $350.00
Early Bird (on or before October 3, 2025): $400.00
Regular Registration (after October 3, 2025):  $425.00

Other Professionals: $150.00

Trainees/Students: $100.00

E-SYLLABUS

We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 

PDF iconLivestream Troubleshooting Tips.pdf

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 3, 2025. No refunds will be issued for refund requests made after October 3, 2025. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Target Audience

This program is designed for clinicians and researchers across various disciplines who are interested in deepening their understanding of psychedelics, both theoretically and practically. It is open to mental health practitioners such as psychiatrists, psychiatric nurse practitioners, social workers, and clinical psychologists, as well as professionals from other fields who are curious about the applications of psychedelics in clinical and research settings.

Accreditation

Accreditation is under review. Please check back soon.

Learning Objectives

Please come back later for this information.

Course summary
Registration opens: 
03/01/2023
Course closes: 
12/31/2025
Event starts: 
11/14/2025 - 8:00am EST
Event ends: 
11/15/2025 - 5:00pm EST
Cost:
$550.00
Add to calendar: 
Rating: 
0

Program

5th Annual Conference on Psychedelics & Psychedelic Medicine
Virtual  

November 14-15, 2025

Agenda

Day 1 – November 14, 2025

8:30-8:40 AM             Welcome & Introduction

Franklin King, MD

MODULE TOPIC 1: Foundations of Psychedelic Research and Practice

8:40–9:00 AM            History & Pharmacology of Psychedelics Basics  

Franklin King, MD

9:00-9:40 AM              Keynote: State of Psychedelic Research in 2025     

David Yaden, PhD

9:40-10:00 AM            Panel Discussion

Moderator: Jerrold Rosenbaum, MD

Panelist: David Yaden, PhD

10:00-10:15 AM           Break

MODULE TOPIC 2: The Neuroscience of Psychedelics

10:15-10:35 AM           Advancing the Cognitive Neuroscience of Psychedelics  

Sharmin Ghaznavi, MD, PhD

10:35-10:55 AM           Beyond the Trip: Classifying Psychedelic Compounds Through Neural Signatures           

Alfred Kaye, MD, PhD

10:55-11:25 AM           Panel Discussion   Moderator: Bruce Rosen, MD

                                        Panelist: Sharmin Ghaznavi, MD, PhD; Alfred Kaye, MD, PhD

MODULE TOPIC 3: Novel Entheogenic Compounds, Natural and Synthetic

11:25-11:45 AM           From Nature to Neuroscience: Novel Plant-Derived Psychedelics & Modeling Human Brain Plasticity with Neurons & Organoids

  Stephen Haggarty, PhD

11:45-12:05 PM           Synthetic Cathinones and PTSD: Investigating Novel Empathogenic Compounds Beyond Psychedelics

  Ben Kelmendi, MD

12:05-12:25 PM           Progress in Novel Entactogens as Therapeutics

                                         Matthew Baggott, PhD

12:25-12:55 PM           Panel Discussion

Moderator: Jerrold Rosenbaum, MD

Panelists: Stephen Haggarty, PhD; Matthew Baggott, PhD

12:55-1:00 PM             Closing Remarks

Franklin King, MD

Day 2 – November 15, 2025

9:00-9:05 AM              Welcome & Introduction

Franklin King, MD

MODULE TOPIC 4: Clinical Frontiers & Ethical Tensions in Psychedelic Psychiatry

9:05-9:25 AM              Psychedelics & Addictions, from Ketamine to Ibogaine

                                       Joji Suzuki, MD  

9:25-9:45 AM              Balancing Risk, Harm & Autonomy: An Ethical Perspective on Psychedelic Research

                                    Brian Earp, PhD 

9:45-10:05 AM            Mood Disorders & Psychedelics: Update on Psychedelic Research for Depression and Bipolar Disorders

                                        Natalie Gukasyan, MD 

10:05-10:35 AM           Panel Discussion

            Moderator: Franklin King, MD

                                    Panelists: Joji Suzuki, MD; Brian Earp, PhD; Natalie Gukasyan, MD 

10:35-10:50 AM           Break

MODULE TOPIC 5: Implementation in Healthcare Settings: Insurance, Reimbursement & Medical Populations

10:50-11:10 AM           Navigating Insurance & Reimbursement Pathways in Psychedelic Therapy

Brian Barnett, MD

11:10-11:30 AM            Ketamine in the General Hospital

Cristina Cusin, MD

11:30-11:50 AM            Psychedelics in Medical Populations: Perspective from a Study of Psilocybin-Assisted Therapy for Irritable Bowel Syndrome

Erin Mauney, MD

11:50-12:20 PM           Panel Discussion

Moderator: Franklin King, MD

Panelists: Brian Barnett, MD; Cristina Cusin, MD; Erin Mauney, MD

12:20-1:20 PM             Lunch Break

MODULE TOPIC 6: Perspectives on Psychedelic-Assisted Therapy

1:20-1:40 PM               On the Differences & Similarities of Working with Patients Using MDMA & Psilocybin

                                         Kelley O’Donnell, MD, PhD

1:40-2:00 PM              Psychedelics in Death & Dying

Yvan Beaussant, MD

2:00-2:20 PM              Psychedelic-Assisted Therapy: Challenges of Capturing the Nuance

Roxanne Sholevar, MD

2:20-2:50 PM              Panel Discussion

            Moderator: Franklin King, MD

Panelists: Kelley O’Donnell, MD, PhD; Yvan Beaussant, MD; Roxanne Sholevar, MD

2:50-3:05 PM              Break

MODULE TOPIC 7: Rules of the Game: Redefining Evidence, Access & Legality in Psychedelic Science

3:05-3:25 PM              Policy & Law in Psychedelics: Navigating Evolving Frameworks                                    

      Allison Hoots, JD

3:25-3:45 PM              Laboratory of the Future? Australia’s prescription psychedelic rollout and other innovations in the Land of Oz                                        

      Paul Liknaitzky, PhD

3:45-4:05 PM              Challenges of Placebo Control in Psychedelic RCTs

Balázs Szigeti, PhD

4:05-4:35 PM              Panel Discussion

            Moderator: Franklin King, MD

Panelists: Allison Hoots, JD; Paul Liknaitzky, PhD; Balázs Szigeti, PhD 

4:35-4:45 PM              Closing Remarks

Franklin King, MD

Faculty

Course Director:

Franklin King, MD
Director, Training and Education, Center for Neuroscience of Psychedelics, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School

Speakers:

Please check back soon for the faculty speaker list.

Register/Take course

Price

Cost:
$550.00
Please login or register to take this course.